Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Legend Biotech (LEGN) Assets Average (2020 - 2025)

Historic Assets Average for Legend Biotech (LEGN) over the last 6 years, with Q3 2025 value amounting to $1.7 billion.

  • Legend Biotech's Assets Average fell 371.1% to $1.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 billion, marking a year-over-year decrease of 371.1%. This contributed to the annual value of $1.8 billion for FY2024, which is 1066.78% up from last year.
  • According to the latest figures from Q3 2025, Legend Biotech's Assets Average is $1.7 billion, which was down 371.1% from $1.7 billion recorded in Q2 2025.
  • In the past 5 years, Legend Biotech's Assets Average registered a high of $745.2 billion during Q2 2021, and its lowest value of $966.6 million during Q4 2021.
  • In the last 5 years, Legend Biotech's Assets Average had a median value of $1.7 billion in 2024 and averaged $94.5 billion.
  • As far as peak fluctuations go, Legend Biotech's Assets Average plummeted by 9972.75% in 2021, and later surged by 4264.79% in 2024.
  • Legend Biotech's Assets Average (Quarter) stood at $966.6 million in 2021, then grew by 11.92% to $1.1 billion in 2022, then soared by 70.45% to $1.8 billion in 2023, then dropped by 7.65% to $1.7 billion in 2024, then fell by 0.09% to $1.7 billion in 2025.
  • Its Assets Average stands at $1.7 billion for Q3 2025, versus $1.7 billion for Q2 2025 and $1.6 billion for Q1 2025.